OTC

Strength

650; 30; 12.5 mg/30mL; mg/30mL; mg/30mL

NDC

70677103301

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

10/17/2023

Pharmacological Classes

Antihistamine
Histamine Receptor Antagonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists

Price History

1W

0.0%

1M

+0.3%

3M

+0.3%

6M

+1.8%

1Y

+5.0%

3Y

N/A

5Y

N/A

All

-2.4%